Stock 3218 UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Universal Vision Biotechnology Co., Ltd.

Equities

3218

TW0003218004

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-07-03 EDT 		5-day change 1st Jan Change
251.5 TWD 0.00% Intraday chart for Universal Vision Biotechnology Co., Ltd. +2.03% -9.21%
05-10 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup
DJ
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes
CI
Universal Vision Biotechnology : Clarification of mass media reporting
PU
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
PU
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer
CI
Universal Vision Biotechnology : The Company is invited to Citi's investor conference call for 1H2022 earnings
PU
Universal Vision Biotechnology : Announcement of 2Q2022 consolidated financial reports approved by the Board of Directors
PU
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
PU
Universal Vision Biotechnology : Announcement of important resolutions of the Company's 2022 General Shareholders'Meeting
PU
Universal Vision Biotechnology : The Company is invited to Fubon Securities’ 2022Q2 Investment Forum Online
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3218 Stock
  4. News Universal Vision Biotechnology Co., Ltd.